Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerance of Nighttime Moisturizing Balm in Atopic Dermatitis
NCT02357940Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Open-label trial of colloidal oatmeal in atopic dermatitis (AD) (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Percentage With Erythema at Day 14, Percentage With Edema at Day 14 and 1 more. Started Jan 2015; status: completed.
02
Drugs
colloidal oatmeal
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02357940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357940.